{"abstract":"The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled \"Male Breast Cancer: Developing Drugs for Treatment.\" This guidance provides recommendations regarding the development and labeling of cancer drugs, including biological products, regulated by the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER) for the treatment of male patients with breast cancer. Specifically, this guidance recommends the inclusion of male patients in clinical trials of breast cancer drugs and provides recommendations on clinical development when males have either not been included in clinical trials for drugs to treat breast cancer or when inclusion of males in those trials is very limited. The development of drugs for male breast cancer may provide clinical data and additional FDA-approved treatment options to improve the clinical management of breast cancer in male patients. The guidance announced in this notice finalizes the draft guidance of the same title issued on August 27, 2019.","action":"Notice of availability.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2020/08/12/2020-17575.html","cfr_references":[],"citation":"85 FR 48706","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"The announcement of the guidance is published in the Federal Register on August 12, 2020.","disposition_notes":null,"docket_ids":["Docket No. FDA-2019-D-2966"],"dockets":[],"document_number":"2020-17575","effective_on":null,"end_page":48708,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2020/08/12/2020-17575.xml","html_url":"https://www.federalregister.gov/documents/2020/08/12/2020-17575/male-breast-cancer-developing-drugs-for-treatment-guidance-for-industry-availability","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2020-17575?publication_date=2020-08-12","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2020-08-12/2020-17575/mods.xml","not_received_for_publication":null,"page_length":3,"page_views":{"count":442,"last_updated":"2026-11-22 12:15:04 -0500"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2020-08-12/pdf/2020-17575.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2020-17575.pdf?1597149923","publication_date":"2020-08-12","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2020/08/12/2020-17575.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":0,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2019-D-2966","supporting_documents_count":0,"docket_id":"FDA-2019-D-2966","document_id":"FDA-2019-D-2966-0025","regulation_id_number":null,"title":"Male Breast Cancer:  Developing Drugs for Treatment; Draft Guidance for Industry; Availability","checked_regulationsdotgov_at":"2020-08-14T08:30:08Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":48706,"subtype":null,"title":"Male Breast Cancer: Developing Drugs for Treatment; Guidance for Industry; Availability","toc_doc":"Male Breast Cancer: Developing Drugs for Treatment","toc_subject":"Guidance:\n","topics":[],"type":"Notice","volume":85}